Keyphrases
Angiogenesis Inhibitors
16%
Antiangiogenic Agents
16%
Apoptosis
16%
Blood Flow
16%
Blood Vessel Formation
16%
Blood Vessels
50%
Cellular Stress
50%
CIP2A
33%
Complementary Approach
100%
Dephosphorylate
16%
Drug Target
16%
Endothelial Cell Apoptosis
100%
Endothelial Cells
50%
Endothelial Viability
16%
Hypoxia-inducible Factor
33%
Mode of Action
16%
Non-pathogenic
16%
Novel Therapeutics
16%
PHD2
33%
Prolyl Hydroxylase Domain 2
16%
Protein Phosphatase 2A (PP2A)
100%
Pruning
33%
Receptor-targeted Therapy
16%
Regulatory Subunit
16%
Stress Conditions
16%
Systemic Administration
16%
Tissue Oxygenation
16%
Tissue Perfusion
16%
Tumor Blood Vessels
16%
Tumor Endothelial Cells
16%
Tumor Growth
16%
Tumor Metastasis
16%
Tumor Progression
16%
Vascular Endothelial Growth Factor Receptor (VEGFR)
16%
Vascular Network Formation
16%
Vascular Plexus
16%
Vascular Remodeling
100%
Vessel Maturation
16%
Vessel Pruning
16%
Vessel Remodeling
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiogenesis Inhibitor
100%
Drug Delivery System
50%
Hypoxia Inducible Factor
100%
Metastasis
50%
Neoplasm
50%
Phosphatase
50%
Phosphoprotein Phosphatase 2
50%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
50%
Systemic Administration
50%
Tumor Growth
100%
Vascular Remodeling
100%
Vascular Tumor
50%
Vasculotropin Receptor
50%
INIS
administration
16%
angiogenesis
16%
apoptosis
100%
blood flow
16%
blood vessels
83%
data
16%
design
16%
drugs
16%
growth
16%
growth factors
16%
hydroxylase
16%
hypoxia
33%
in vivo
16%
machinery
16%
maturation
33%
metastases
16%
oxygen
33%
phosphatases
33%
phosphorus 38
16%
proteins
16%
receptors
16%
restoration
16%
stabilization
16%
therapy
16%
tissues
16%
tumors
66%
vessels
100%
Medicine and Dentistry
Angiogenesis
16%
Angiogenesis Inhibitor
33%
Blood Flow
16%
Cell Stress
50%
Cell Survival
16%
Drug Delivery System
16%
Endothelial Cell
100%
Hypoxia Inducible Factor
33%
Maturation
33%
Metastatic Carcinoma
16%
Neoplasm
16%
Perfusion
16%
Phosphatase
16%
Phosphoprotein Phosphatase 2
16%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
16%
Programmed Cell Death
100%
Systemic Administration
16%
Targeted Therapy
16%
Tumor Progression
33%
Vascular Network
16%
Vascular Plexus
16%
Vascular Remodeling
100%
Vascular Tissue Neoplasm
16%
Vasculotropin Receptor
16%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
66%
Blood Flow
33%
Cell Count
33%
Cell Stress
100%
Cell Survival
33%
Drug Targeting
33%
Hypoxia-Inducible Factors
66%
Maturation
66%
Phosphatase
33%
Procollagen-Proline Dioxygenase
33%
Protein Phosphatase 2
33%
Tissue Perfusion
33%
Tumor Progression
66%
VEGF Receptors
33%